[Characteristics of immunoglobulin heavy-chain gene clonal rearrangements by next-generation sequencing of patients with multiple myeloma] [0.03%]
二代测序技术检测多发性骨髓瘤患者免疫球蛋白重链基因克隆性重组的特征分析
L Yao,Y Chen,Y Y Zhai et al.
L Yao et al.
[Clinical and biological characteristics and prognosis of patients with biclonal multiple myeloma] [0.03%]
双克隆性多发性骨髓瘤患者的临床及生物学特点和预后研究
W Cheng,Y L Li,Z F Huang et al.
W Cheng et al.
[Erdheim-Chester Disease presenting with exophthalmos, impaired vision, and retroperitoneal fibrosis: a case report and literature review] [0.03%]
[伴有突眼、视力障碍和肾周纤维化的Erdheim Chester病1例及文献复习]
T H He,A L Zhao,N Niu et al.
T H He et al.
[A predictive model based on risk factors for early mortality in patients with newly diagnosed multiple myeloma] [0.03%]
[新诊断多发性骨髓瘤患者早期死亡风险因素的预测模型]
M R Tian,P Y Yang,T T Yue et al.
M R Tian et al.
Objective: To investigate risk factors for early mortality (EM) in patients with newly diagnosed multiple myeloma (NDMM) and to build an EM-predictive model. Methods: In a cohort of 275 patients with NDMM, risk factors for EM at 6, 12, and ...
[Analysis of clinical features and prognosis of patients with chronic myelogenous leukemia harboring additional chromosomal abnormalities in Ph-positive cells] [0.03%]
费城染色体阳性慢性髓系白血病患者附加染色体异常的临床特征及预后分析
X Y Dong,Y L Li,C Y Wu et al.
X Y Dong et al.
Objective: To investigate the effects of additional chromosomal abnormalities (ACA) in Philadelphia chromosome-positive (Ph(+)) cells on biological characteristics, therapy efficacy, and prognosis of patients with primary chronic myeloid le...
[The hematological diversity of human parvovirus B19 infection after allo-hematopoietic stem cell transplantation in pediatric patients] [0.03%]
异体造血干细胞移植后儿科患者人细小病毒B19感染的血液学多样性
L Y Zhang,F Liu,X Chen et al.
L Y Zhang et al.
Objective: To retrospectively analyze hemogram and bone marrow characteristics of pediatric patients infected with parvovirus B19 (HPV-B19) after hematopoietic reconstitution following allo-hematopoietic stem cell transplantation. Methods: ...
[Prognostic value of KIT and other clonal genetic mutations in core-binding factor acute myeloid leukemia] [0.03%]
KIT及其他克隆遗传突变在核心结合因子急性髓系白血病预后中的价值
T M Wu,S L Xue,Z Li et al.
T M Wu et al.
Objective: To evaluate the prognostic significance of clonal gene mutations using next-generation sequencing in patients with core-binding factor acute myeloid leukemia (CBF-AML) who achieved first complete remission after induction chemoth...
[Clinical characteristics of patients with multiple myeloma harboring 6q deletion] [0.03%]
伴有6号染色体臂缺失多发性骨髓瘤患者的临床特征分析
L Chen,C Y Sun,B W An et al.
L Chen et al.
Objective: To study the clinical and cytogenetic characteristics of patients with multiple myeloma harboring 6q deletion, with the aim to determine the impact of 6q deletion on survival. Methods: This study included the retrospective analys...
[The relationship between symptom burden and hematologic responses after treatment with interferon/hydroxyurea in patients with polycythemia vera] [0.03%]
干扰素/羟基脲治疗后多血症患者症状负担与血液学反应之间的关系
D Liu,Z F Xu,T J Qin et al.
D Liu et al.
Objective: To explore the relationship between symptom burden and hematologic responses after treatment with interferon and/or hydroxyurea in patients with polycythemia vera (PV) . Methods: Hematologic responses after continuous treatment w...